Skip to main content
IMMUPHARMA PLC logo

IMMUPHARMA PLC — Investor Relations & Filings

Ticker · IMM ISIN · GB0033711010 LEI · 213800VZKGHXC7VUS895 IL Professional, scientific and technical activities
Open in API
Filings indexed 443 across all filing types
Latest filing 2020-06-02 Regulatory Filings
Country GB United Kingdom
Listing IL IMM

About IMMUPHARMA PLC

https://www.immupharma.co.uk/

ImmuPharma PLC is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The company's primary focus is on creating novel treatments for serious medical conditions with significant unmet needs. Its core activities involve advancing a pipeline of drug candidates through research and various stages of clinical development, leveraging its expertise in peptide technology.

Recent filings

Filing Released Lang Actions
Notification of Change of AGM Venue
Regulatory Filings Classification · 1% confidence The document is explicitly titled "Notification of Change of AGM Venue" and discusses the logistics and location change for the Annual General Meeting (AGM) scheduled for June 18, 2020. While it relates to the AGM, it is not the presentation material (AGM-R) or the proxy solicitation materials (PSI). It is a specific announcement regarding the meeting logistics, which falls under general corporate announcements related to shareholder meetings. Since there is no specific code for 'AGM Logistics Change', and it is a formal announcement concerning the AGM, the closest fit among the provided options is AGM Information (AGM-R), as it directly pertains to the AGM event itself, even if it's a venue change rather than presentation slides. However, given the nature of the announcement (a simple notification of a venue change due to COVID-19), it could also be considered a general Regulatory Filing (RNS). Since the core subject is the AGM, AGM-R is the most specific category related to the event.
2020-06-02 English
Notice of AGM and posting of Report & Accounts
Report Publication Announcement Classification · 1% confidence The document is an RNS announcement (indicated by 'RNS Number' and 'RNS: RELEASE') from ImmuPharma PLC. The title explicitly states 'Notice of AGM and posting of Report & Accounts'. The text confirms that the 'Annual Report and Accounts for the year ended 31 December 2019, and the Notice of Annual General Meeting has been posted to shareholders.' Since this document is an announcement *about* the posting of the Annual Report and the Notice of AGM, and it is short (4286 chars), it fits the criteria for a Report Publication Announcement (RPA) rather than the full 10-K or AGM-R documents themselves. However, because it specifically announces the availability of the AGM Notice, it also strongly relates to AGM-R materials. Given the dual nature, and the explicit mention of the AGM details (date, time, COVID restrictions), AGM-R is a strong candidate, but RPA covers the act of announcing the availability of reports. Since the primary action described is the *posting* of the AGM Notice and the Annual Report, RPA is the most accurate classification based on the 'MENU VS MEAL' rule, as it is an announcement of publication. If the document were the full AGM presentation or the full 10-K, the classification would change. Given the strong presence of AGM details, I will prioritize AGM-R as the core subject matter being announced, but RPA is also highly relevant. Re-evaluating: The document contains the Notice of AGM itself (which is a key component of AGM-R materials) alongside the announcement of the Report & Accounts. Since the AGM details are central, AGM-R is slightly more specific than the general RPA.
2020-05-21 English
IMM Notice of AGM May 2020.pdf
AGM Information Classification · 1% confidence The document is explicitly titled "NOTICE OF THE 2020 ANNUAL GENERAL MEETING of ImmuPharma plc". It details the date, time, location (and subsequent restrictions due to COVID-19), the ordinary and special resolutions to be proposed, and instructions for appointing proxies. This content is the core material associated with convening and conducting an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2020-05-21 English
ImmuPharma Annual Report 31.12.2019 FINAL.pdf
Annual Report Classification · 1% confidence The document is titled 'ImmuPharma plc Report and Consolidated Financial Statements For the Year Ended 31 December 2019'. It contains a comprehensive table of contents including a Chairman's Report, Strategic Report, Directors' Report, Independent Auditor's Report, and full Consolidated Financial Statements (Income Statement, Balance Sheet, Cash Flows, etc.). Given the length, the inclusion of audited financial statements, and the reporting period covering a full fiscal year, this is clearly an Annual Report. FY 2019
2020-05-21 English
IMM Blank Proxy for 18 June 2020 AGM.pdf
AGM Information Classification · 1% confidence The document is explicitly titled 'Form of Proxy - Annual General Meeting to be held on 18 June 2020'. It contains instructions for appointing a proxy, details about voting on Ordinary and Special Resolutions (including receiving accounts, re-appointing directors/auditors, share allotment, and amending Articles of Association), and deadlines for lodging the proxy form. This material is directly related to soliciting shareholder votes for the Annual General Meeting (AGM). While it is a proxy form, which is often distributed alongside the Notice of Meeting (which might fall under PSI), the core function here is facilitating the AGM process and voting. Given the options, 'AGM Information (AGM-R)' is the most appropriate classification as it covers presentations and materials shared during the AGM, and proxy forms are integral materials for that event. It is not a DEF 14A (Remuneration) or a DVA (Declaration of Voting Results), but the mechanism for voting at the AGM.
2020-05-21 English
IMM RNS Posting of RA and Notice of AGM May 2020.pdf
Report Publication Announcement Classification · 1% confidence The document is explicitly titled "Notice of AGM and posting of Report & Accounts" and is released via RNS (Regulatory News Service). It states that the Annual Report and Accounts for the year ended 31 December 2019, AND the Notice of Annual General Meeting have been posted to shareholders and are available for download. The document itself is short (4163 chars) and primarily serves to announce the availability of the full reports and provide details about the upcoming AGM (including COVID-19 restrictions preventing physical attendance). Because it announces the publication of the Annual Report and the AGM notice, and is itself a regulatory announcement, it fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since it specifically mentions the AGM and the posting of the Annual Report, RPA is a strong candidate, but RNS is the general regulatory announcement category. Given the content is a formal notice about the AGM and the posting of reports, RPA (Report Publication Announcement) is the most precise fit for announcing the availability of the 'Report & Accounts' and the 'Notice of AGM'. However, since the document also contains the AGM notice details and is an RNS release, and RPA is defined as announcing the *timing* or *release* of reports, this document is the announcement itself. I will classify it as RPA because it announces the posting of the Annual Report and the AGM notice, adhering to the 'MENU VS MEAL' rule.
2020-05-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.